Enzobrics Tablet is a combination pharmaceutical formulation containing Trypsin 48mg, Bromelain 90mg, Rutoside 100mg, and Diclofenac 50mg, designed to provide effective anti-inflammatory, analgesic, and fibrinolytic actions. Trypsin and Bromelain are proteolytic enzymes that facilitate the breakdown of protein-based inflammatory mediators, thereby reducing edema and promoting faster resolution of inflammation. Rutoside, a bioflavonoid, enhances capillary strength and reduces vascular permeability, contributing to decreased tissue swelling and improved microcirculation. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase enzymes, leading to reduced synthesis of prostaglandins responsible for pain, inflammation, and fever. The synergistic effect of these components makes Enzobrics Tablet particularly useful in managing acute musculoskeletal conditions such as sprains, strains, contusions, and post-operative inflammation. It may also be indicated for chronic inflammatory disorders where enzyme therapy and NSAID action are beneficial. The tablet should be administered as per physician’s guidance, considering contraindications such as hypersensitivity to NSAIDs, peptic ulcer disease, and bleeding disorders. Caution is advised in patients with hepatic or renal impairment. Enzobrics Tablet offers a comprehensive approach to inflammation management by combining enzymatic and pharmacological mechanisms to enhance patient recovery and comfort.